Pasithea Therapeutics Corp.

UBS Group AG KTTA
Report date
9/30/2023
Quarter
2023 Q3
Filed
11/9/2023
Shares
83
Value ($000)
0
Weight
0.0%
2021 Q3 - 2023 Q3 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).